Our data indicate that immunological abnormalities in patients with EDA-ID, ID, and NDAS are primarily antibody deficiencies, predominantly IgG deficiency; varying levels of abnormalities in IgM and IgA antibodies may accompany them. This evidence concerns the gene CD79A and hyperinsulinemic hypoglycemia, familial, 4.